HomeNewsParenteral drugs

Parenteral Drugs

Jump to

Parenteral Drugs sells its arm's Goa unit, stock falls 9%

Parenteral Drugs (India) dropped nearly 18 percent from day's high on Friday after the company sold its subsidiary's Goa unit to Fresenius Kabi.
Will use sale proceeds to diversify operations: Parenteral

Parenteral Drugs (India) sold their IV Fluid manufacturing unit at Goa to Fersenius Kabi India (P) Limited for Rs 200 crore.
BSE to shift 81 scrips into Trade-to-Trade segment

As a part of surveillance measures, the Bombay Stock Exchange is going to transfer 81 scrips for settlement on a trade-to-trade basis. Some of them are 3i Infotech, Marksans Pharma, Moser Baer, Parenteral Drugs and Piramal Life Sciences.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Parenteral Drugs

Parenteral Drugs sells its arm's Goa unit, stock falls 9%

Will use sale proceeds to diversify operations: Parenteral

BSE to shift 81 scrips into Trade-to-Trade segment